STENDRA

Drug Akrimax Pharmaceuticals, LLC
Total Payments
$49,800
Transactions
21
Doctors
16
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $49,800 21 16

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $49,800 21 100.0%

Top Doctors Receiving Payments for STENDRA

Doctor Specialty Location Total Records
, MD Urology Royal Oak, MI $6,525 3
, MD Urology Miami, FL $5,850 2
, M.D Urology Monroeville, PA $5,175 2
, MD Urology Tampa, FL $4,050 2
, D.O Urology Bala Cynwyd, PA $3,000 1
, MD Urology Austin, TX $2,925 1
, MD Urology Glendora, CA $2,700 1
, MD Urology San Diego, CA $2,700 1
, M.D Specialist Aventura, FL $2,700 1
, MD Urology Brighton, MA $2,475 1
, MD Urology San Antonio, TX $2,250 1
, MD Urology Middleburg Heights, OH $2,250 1
, MD Urology Millburn, NJ $1,800 1
, M.D Urology Encino, CA $1,800 1
, DO General Practice Brodheadsville, PA $1,800 1
, MD Urology Indianapolis, IN $1,800 1

About STENDRA

STENDRA is a drug associated with $49,800 in payments to 16 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Akrimax Pharmaceuticals, LLC.

Payment data is available from 2017 to 2017. In 2017, $49,800 was paid across 21 transactions to 16 doctors.

The most common payment nature for STENDRA is "Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program" ($49,800, 100.0% of total).